Investor Ikarian Capital, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ikarian Capital, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13G/A FBRX / Forte Biosciences, Inc. 609,225 617,667
2025-05-15 13G/A AVTX / Avalo Therapeutics, Inc. 970,359 1,191,957
2025-05-15 13G CPIX / Cumberland Pharmaceuticals Inc. 730,932
2025-05-15 13G/A TRAW / Traws Pharma, Inc. 394,255 589,502
2025-02-14 13G ATXI / Avenue Therapeutics, Inc. 140,000
2025-02-14 13G GRTX / Galera Therapeutics, Inc. 7,538,690
2025-02-14 13G AEMD / Aethlon Medical, Inc. 1,229,285
2025-02-14 13G TRAW / Traws Pharma, Inc. 394,255
2025-02-14 13G FBRX / Forte Biosciences, Inc. 609,225
2025-02-14 13G CHRO / Channel Therapeutics Corporation 440,849
2025-02-14 13G ACOG / Alpha Cognition Inc. 967,867
2024-11-14 13G/A TCON / TRACON Pharmaceuticals, Inc. 2,670,930 133,404
2024-11-14 13G IBIO / iBio, Inc. 599,913
2024-10-07 13G AVTX / Avalo Therapeutics, Inc. 970,359
2024-04-05 13G/A TCON / TRACON Pharmaceuticals, Inc. 2,765,530 2,670,930
2024-02-14 13G/A BLCM / Bellicum Pharmaceuticals, Inc. 448,101 448,101
2023-02-14 13G/A TCON / TRACON Pharmaceuticals, Inc. 2,691,110 2,765,530
2023-02-14 13G/A XFOR / X4 Pharmaceuticals, Inc. 2,264,491 349,133
2023-02-14 13G/A MIST / Milestone Pharmaceuticals Inc. 1,750,043 460,416
2023-02-14 13G/A BLCM / Bellicum Pharmaceuticals, Inc. 496,756 448,101
2022-02-14 13G/A BLCM / Bellicum Pharmaceuticals, Inc. 500,000 496,756
2022-02-14 13G/A CYCC / Bio Green Med Solution, Inc. 400,000 99,422
2022-02-14 13G/A SCPH / scPharmaceuticals Inc. 1,466,147 901,362
2022-02-14 13G/A TARA / Protara Therapeutics, Inc. 649,542 279,256
2022-02-14 13G/A LIFE / aTyr Pharma, Inc. 888,580 35,048
2022-02-14 13G/A LSAQ / LifeSci Acquisition II Corp 512,450 0
2022-02-14 13G/A TPST / Tempest Therapeutics, Inc. 1,348,021 58,803
2022-02-14 13G/A XFOR / X4 Pharmaceuticals, Inc. 2,624,988 2,264,491
2022-02-14 13G/A TCON / TRACON Pharmaceuticals, Inc. 2,716,840 2,691,110
2022-02-14 13G/A ODT / Odonate Therapeutics Inc 1,986,412 1,340,631
2022-02-14 13G/A MIST / Milestone Pharmaceuticals Inc. 1,836,545 1,750,043
2022-02-14 13G/A LYRA / Lyra Therapeutics, Inc. 815,364 394,536
2022-02-14 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,063,961 36,576
2021-09-17 13G LIFE / aTyr Pharma, Inc. 888,580
2021-07-02 13G ODT / Odonate Therapeutics Inc 1,986,412
2021-04-08 13G/A XFOR / X4 Pharmaceuticals, Inc. 826,424 2,624,988
2021-04-07 13G TPST / Tempest Therapeutics, Inc. 1,348,021
2021-02-16 13G/A TCON / TRACON Pharmaceuticals, Inc. 2,162,549 2,716,840
2021-02-16 13G/A KALV / KalVista Pharmaceuticals, Inc. 946,605 1,063,961
2021-02-16 13G/A LYRA / Lyra Therapeutics, Inc. 785,364 815,364
2021-02-12 13G/A TARA / Protara Therapeutics, Inc. 307,308 649,542
2021-02-12 13G/A SCPH / scPharmaceuticals Inc. 1,073,647 1,466,147
2021-02-12 13G/A CLDX / Celldex Therapeutics, Inc. 1,592,439 1,364,990
2021-02-12 13G/A VSTM / Verastem, Inc. 5,051,875 2,254,591
2021-02-12 13G/A YMTX / Yumanity Therapeutics Inc 2,650,347 132,514
2021-02-12 13G/A SBBP / Strongbridge Biopharma plc 3,242,787 2,440,028
2021-01-11 13G BLCM / Bellicum Pharmaceuticals, Inc. 500,000 500,000
2021-01-11 13G AADI / Aadi Bioscience, Inc. 475,778 475,778
2021-01-11 13G CYCC / Bio Green Med Solution, Inc. 400,000 400,000
2021-01-11 13G LSAQ / LifeSci Acquisition II Corp 512,450
2021-01-11 13G MIST / Milestone Pharmaceuticals Inc. 1,836,545
2021-01-11 13G AADI / Aadi Bioscience, Inc. 475,778 475,778
2021-01-11 13G BLCM / Bellicum Pharmaceuticals, Inc. 500,000 500,000
2021-01-09 13G CYCC / Bio Green Med Solution, Inc. 400,000
2020-12-30 13G LYRA / Lyra Therapeutics, Inc. 785,364
2020-12-30 13G XFOR / X4 Pharmaceuticals, Inc. 826,424
2020-11-18 13G YMTX / Yumanity Therapeutics Inc 2,650,347
2020-09-14 13G TCON / TRACON Pharmaceuticals, Inc. 2,162,549
2020-06-18 13G CLDX / Celldex Therapeutics, Inc. 1,592,439
2020-03-23 13G KALV / KalVista Pharmaceuticals, Inc. 946,605
2020-03-23 13G SCPH / scPharmaceuticals Inc. 1,073,647
2020-03-19 13G SBBP / Strongbridge Biopharma plc 3,242,787
2020-03-09 13G VSTM / Verastem, Inc. 5,051,875
2020-02-21 13G TARA / Protara Therapeutics, Inc. 307,308